news
« BACK
History / Archeology - Career - 05.03.2018
Health - Career - 23.03.2017
Career
Results 1 - 2 of 2.
Ancient Nubia (present-day Sudan) : In the footsteps of the Napata and Meroe kingdoms
The archaeological site of Sedeinga is located in Sudan, a hundred kilometers to the north of the third cataract of the Nile, on the river's western shore. Known especially for being home to the ruins of the Egyptian temple of Queen Tiye, the royal wife of Amenhotep III, the site also includes a large necropolis containing sepulchers dating from the kingdoms of Napata and Mereo (seventh century BCE–fourth century CE), a civilization 1 mixing local traditions and Egyptian influences.
The archaeological site of Sedeinga is located in Sudan, a hundred kilometers to the north of the third cataract of the Nile, on the river's western shore. Known especially for being home to the ruins of the Egyptian temple of Queen Tiye, the royal wife of Amenhotep III, the site also includes a large necropolis containing sepulchers dating from the kingdoms of Napata and Mereo (seventh century BCE–fourth century CE), a civilization 1 mixing local traditions and Egyptian influences.
Stimunity Signs an Exclusive License Agreement with Institut Curie and Inserm
Paris, March 21st, 2017 - Stimunity, Institut Curie and Inserm are pleased to announce that the company has signed an exclusive worldwide license agreement on two key patents that cover Stimunity's core technology VLP-cGAMP to develop new drugs in immuno-oncology. All started with a fundamental discovery made by the laboratory Innate Immunity at Institut Curie, leads by Dr. Nicolas Manel, Senior Researcher at Inserm and co-founder of Stimunity.
Paris, March 21st, 2017 - Stimunity, Institut Curie and Inserm are pleased to announce that the company has signed an exclusive worldwide license agreement on two key patents that cover Stimunity's core technology VLP-cGAMP to develop new drugs in immuno-oncology. All started with a fundamental discovery made by the laboratory Innate Immunity at Institut Curie, leads by Dr. Nicolas Manel, Senior Researcher at Inserm and co-founder of Stimunity.